Asthma. Asthma
Conditions
Interventions
Intervention 1: Intervention group: Take a 40 mg nanocurcumin capsule (Elixir Nanosina pharmaceutical company) and a 1000 mg omega-3 capsule (Karen pharmaceutical company) daily for 8 weeks. Intervent
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients with asthma diagnosed by a doctor Asthma patients with an age range of 15 to 60 years
Exclusion criteria
Exclusion criteria: Users of systemic drugs, NSAIDs, immunosuppressive drugs NSAID users Users of immunosuppressive drugs People with COPD Cardiovascular patients Kidney patients Liver patients Gastrointestinal patients Autoimmune patients suffering from reflexes Lactating lady pregnant lady People addicted to tobacco Allergy and intolerance to curcumin Allergy and intolerance to fish oil Consumption of food supplements and antioxidants from 2 months before and during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life of patients with asthma. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Asthma control questionnaire.;Measurement of airway inflammation in patients with asthma. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Measurement of exhaled nitric oxide through the FeNo device. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life questionnaire score of patients with asthma. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Evaluation of the quality of life questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyedeh tayebeh rahideh
Iran University of Medical Sciences
Outcome results
None listed